OLISVIER ORTIZ: Open Payments
NPI 1932645587 · JENKINTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 25 payments from 12 companies in 2025. Trend: 2023 $95 · 2024 $741 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $141 |
| Lilly USA, LLC | 4 | $117 |
| PFIZER INC. | 4 | $67 |
| Biogen, Inc. | 2 | $45 |
| Dexcom, Inc. | 1 | $39 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $22 |
Products named: JARDIANCE, Wegovy, PREVNAR 20, Dexcom G6 Transmitter, VAXNEUVANCE, BREZTRI, SKYCLARYS, OPSUMIT.
Industry payments across PA — which companies pay providers there.
